E1A signaling to p53 involves the p19<sup>ARF</sup>tumor suppressorElisa de Stanchina, Scott Lowe|Genes & Development|1998Cited by 610
Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer ModelingJuliann Chmielecki, William Pao, Akira Inoue et al.|Science Translational Medicine|2011Cited by 530
Overcoming mTOR resistance mutations with a new-generation mTOR inhibitorVanessa Rodrik-Outmezguine, Kevan M. Shokat, Masanori Okaniwa et al.|Nature|2016Cited by 483
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate CancerZeda Zhang, Charles L. Sawyers, Wouter R. Karthaus et al.|Cancer Cell|2020Cited by 252
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Michael R. Green, Saber Tadros et al.|Cancer Discovery|2020Cited by 159